Status:
UNKNOWN
Fibromyalgia During the COVID-19 Pandemic
Lead Sponsor:
Al-Azhar University
Conditions:
Fibromyalgia, Primary
Eligibility:
All Genders
19+ years
Brief Summary
On 12 January 2020, the World Health Organization (WHO) confirmed that a novel coronavirus was the cause of a respiratory illness in a cluster of people in Wuhan City, Hubei Province, China, which was...
Detailed Description
The first confirmed case relating to the COVID-19 pandemic in the United Arab Emirates was announced on 29 January 2020. On March 11, the World Health Organization (WHO) declared the global outbreak ...
Eligibility Criteria
Inclusion
- Patients aged \> 18 year
- Diagnosis of primary fibromyalgia
- Newly diagnosed and follow up patients are included
- Patients who have physically attended the rheumatology clinic during the study period.
Exclusion
- Patients aged \< 18-year-old
- Patients with inflammatory arthritis and associated FM (Secondary FM)
- Patients who didn't physically attend the rheumatology clinics (Those who used Phone calls and other telemedicine platforms).
Key Trial Info
Start Date :
March 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2020
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04422522
Start Date
March 15 2020
End Date
June 30 2020
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Azhar Faculty of medicine, Rheumatology Department
Cairo, Egypt, 11311